Lyell Immunopharma, Inc. (LYEL)
NASDAQ: LYEL · Real-Time Price · USD
11.97
-1.08 (-8.28%)
At close: Jun 5, 2026, 4:00 PM EDT
12.20
+0.23 (1.92%)
After-hours: Jun 5, 2026, 6:30 PM EDT
Lyell Immunopharma Employees
Lyell Immunopharma had 161 employees as of December 31, 2025. The number of employees decreased by 139 or -46.33% compared to the previous year.
Employees
161
Change (1Y)
-139
Growth (1Y)
-46.33%
Revenue / Employee
$193
Profits / Employee
-$1,530,472
Market Cap
279.31M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 161 | -139 | -46.33% | 161 | 0 |
| Dec 31, 2024 | 300 | 76 | 33.93% | 300 | 0 |
| Dec 31, 2023 | 224 | -50 | -18.25% | 224 | 0 |
| Dec 31, 2022 | 274 | 55 | 25.11% | 274 | 0 |
| Dec 31, 2021 | 219 | 29 | 15.26% | 219 | 0 |
| Mar 31, 2021 | 190 | - | - | 188 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| Niagen Bioscience | 117 |
| Silence Therapeutics | 88 |
| Lineage Cell Therapeutics | 77 |
| InflaRx | 65 |
| Armata Pharmaceuticals | 61 |
| Immuneering | 55 |
| Inhibikase Therapeutics | 35 |
LYEL News
- 2 days ago - Lyell Immunopharma to Present Phase 1/2 Safety and Translational Data for Ronde-Cel in Large B-Cell Lymphoma at the European Hematology Association 2026 Congress - GlobeNewsWire
- 6 days ago - Lyell Immunopharma Announces Participation in Goldman Sachs 47th Annual Global Healthcare Conference 2026 - GlobeNewsWire
- 17 days ago - Lyell Immunopharma Transcript: Stifel 2026 Targeted Oncology Virtual Forum - Transcripts
- 18 days ago - Lyell Immunopharma Transcript: H.C. Wainwright 4th Annual BioConnect Investor Conference - Transcripts
- 26 days ago - Lyell Immunopharma Announces Participation in May Investor Conferences - GlobeNewsWire
- 4 weeks ago - Lyell Immunopharma Reports Business Highlights and Financial Results for the First Quarter 2026 - GlobeNewsWire
- 4 weeks ago - Lyell Immunopharma Quarterly report: Q1 2026 - Filings
- 4 weeks ago - Lyell Immunopharma Earnings release: Q1 2026 - Filings